title: Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry.
abstract: Although vinyl chloride is an established cause of liver angiosarcoma, the evidence is inconclusive on whether it also causes other neoplastic and nonneoplastic chronic liver diseases as well as neoplasms in other organs. Furthermore, the shape of the dose-response relation for angiosarcoma is uncertain. We have extended for approximately 8 years the mortality and cancer incidence follow-up of 12,700 male workers in the vinyl chloride industry in four European countries. All-cause mortality was lower than expected, whereas cancer mortality was close to expected. A total of 53 deaths from primary liver cancer (standardized mortality ratio 2.40, 95% confidence interval = 1.80-3.14) and 18 incident cases of liver cancer were identified, including 37 angiosarcomas, 10 hepatocellular carcinomas, and 24 liver cancers of other and unknown histology. In Poisson regression analyses we observed a marked exposure response for all liver cancers, angiosarcoma, and hepatocellular carcinoma. The exposure-response trend estimated for liver cancer in analyses restricted to cohort members with cumulative exposures of <1,500 parts per million-years was close to that estimated for the full cohort (relative risk of 2.0 per logarithmic unit of cumulative dose). No strong relation was observed between cumulative vinyl chloride exposure and other cancers. Although cirrhosis mortality was decreased overall, there was a trend with cumulative exposure.
authors.affiliation: Unit of Environmental Cancer Epidemiology, International Agency for Research on Cancer, Lyon, France.
authors.forename: E
authors.initials: E
authors.lastname: Ward
authors.forename: P
authors.initials: P
authors.lastname: Boffetta
authors.forename: A
authors.initials: A
authors.lastname: Andersen
authors.forename: D
authors.initials: D
authors.lastname: Colin
authors.forename: P
authors.initials: P
authors.lastname: Comba
authors.forename: J A
authors.initials: JA
authors.lastname: Deddens
authors.forename: M
authors.initials: M
authors.lastname: De Santis
authors.forename: G
authors.initials: G
authors.lastname: Engholm
authors.forename: L
authors.initials: L
authors.lastname: Hagmar
authors.forename: S
authors.initials: S
authors.lastname: Langard
authors.forename: I
authors.initials: I
authors.lastname: Lundberg
authors.forename: D
authors.initials: D
authors.lastname: McElvenny
authors.forename: R
authors.initials: R
authors.lastname: Pirastu
authors.forename: D
authors.initials: D
authors.lastname: Sali
authors.forename: L
authors.initials: L
authors.lastname: Simonato
mesh_terms: D002273:Carcinogens / Q000009:adverse effects*; D002423:Cause of Death; D002617:Chemical Industry; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006394:Hemangiosarcoma / Q000139:chemically induced* / Q000401:mortality; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000401:mortality; D008297:Male; D009369:Neoplasms / Q000139:chemically induced / Q000401:mortality; D016273:Occupational Exposure / Q000009:adverse effects* / Q000706:statistics & numerical data; D016012:Poisson Distribution; D012044:Regression Analysis; D014752:Vinyl Chloride / Q000009:adverse effects*
chemical_list: D002273:Carcinogens; D014752:Vinyl Chloride